Juvenile psoriatic arthritis is the most common type of arthritis in children and teens. Learn the symptoms, diagnosis, and treatment options. Psoriatic arthritis (PsA) is an autoimmune disease that occurs because the immune system mistakenly attacks healthy body tissues, namely the joints and entheses (the areas where tendons and ligaments meet bone).According to the National Psoriasis
Psoriatic arthritis (PsA) is an autoimmune disease that occurs because the immune system mistakenly attacks healthy body tissues, namely the joints and entheses (the areas where tendons and ligaments meet bone).
According to the National Psoriasis Foundation (NPF), PsA affects up to 30% of people with the autoimmune skin disease psoriasis. In psoriasis, the immune system mistakenly attacks healthy skin cells leading to the accelerated growth of new cells that build up to form plaques (red patches of flaky, crusty skin).
But PsA is not limited to people with psoriasis, and anyone can develop the condition, including children and teenagers. When children and teens get PsA, the condition is called juvenile PsA.
Juvenile PsA is a type of juvenile idiopathic arthritis (JIA) and is extremely rare. It is called idiopathic because it has no known cause. According to NPF, JIA occurs in around 20 to 45 children per 100,000 children. Of those, about 5% have PsA.
This article will cover the symptoms of juvenile PsA, its causes and risk factors, treatment, and more.
undefined undefined / Getty Images
The symptoms of juvenile PsA are the same as those experienced in adult PsA. It is possible to experience juvenile psoriasis before a child has any signs of PsA, but that is not always the case. Some children will develop arthritis symptoms first, and others will never get psoriasis.
Symptoms will vary among children and may include:
Sometimes, symptoms of juvenile PsA are asymmetric (affecting only one side of the body), but over time, they may become symmetric (affecting both sides).
The causes of JIA are unknown, and researchers do not know what causes the immune system to turn against its joints and skin. They suspect that genes and environmental factors might be to blame. Children with juvenile PsA often have a first-degree relative (parent or full sibling) with PsA or psoriasis, or a personal history of psoriasis.
Why some children develop juvenile PsA and others do not is a question that researchers have been trying to answer, and they suspect that genetics might be a risk factor for the condition.
According to the NPF, more than half of children who develop PsA have at least one family member who has psoriasis. Genetic studies have found links with specific genes that might predispose someone to PsA.
Additional risk factors for PsA in children are:
Like adult PsA, juvenile PsA tends to be more frequently diagnosed in children who are White and non-Hispanic. One 2018 literature review looked at a cohort of 361 children with PsA, most of whom were later identified to be White (93.9%) and non-Hispanic (91.7%).
A rheumatologist (a specialist in non-surgical treatment of arthritis and other diseases of the muscles, joints, and bones) can diagnose juvenile PsA with a physical examination, including a complete medical and symptom history, laboratory tests, and imaging.
During the physical exam, the rheumatologist will ask about the child's symptoms, medical history, and any family history of psoriasis or PsA. During the physical exam, they will look for the following:
If your child has eye redness or pain, their doctor will make a referral to a pediatric ophthalmologist (eye doctor). An eye exam can look for uveitis (swelling of the eye's middle layer).
There is no single lab test that confirms juvenile PsA. However, some lab tests can rule out other diseases with similar symptoms.
Blood tests might include:
If your child's healthcare provider suspects PsA, they will request imaging studies—X-rays, magnetic resonance imaging (MRI), and ultrasound scans. Imaging for juvenile PsA can reveal the presence and extent of joint inflammation and help your child's healthcare provider distinguish arthritis from other inflammatory conditions.
Imaging is helpful because PsA is known for causing bone and joint destruction very early on. Also, these bone and joint changes are rarely seen with other types of inflammatory arthritis.
Untreated juvenile PsA can lead to different disease complications. These might include:
Treatment for juvenile PsA will depend on your child's symptoms, disease severity, age, and overall health. Treatment will manage both skin symptoms and joint inflammation. The goals of PsA treatment are to reduce damaging inflammation, maintain mobility and prevent joint deformity and severe disease complications.
You can help your child learn how to manage juvenile PsA using different home remedies and lifestyle remedies. These might include:
Nonsteroidal anti-inflammatory drugs (NSAIDs) can provide pain relief and reduce swelling. Most are available without a prescription. NSAIDs include Advil (ibuprofen) and Aleve (naproxen).
Corticosteroids can be given to children as an injection in a single joint. A corticosteroid can be given orally as a pill, but healthcare providers try to avoid this because long-term steroid use can interfere with a child's growth.
DMARDs suppress an overactive immune system and reduce inflammation. The goal of these medicines is to prevent bone and joint destruction.
Mexate (methotrexate) is the most commonly prescribed DMARD for juvenile PsA, and is often given as an injection to children. Other DMARDs for juvenile PsA are Arava (leflunomide) and Azulfidine (sulfasalazine).
Biologics are medicines that target specific proteins in the immune system responsible for inflammation. They are available as subcutaneous injections or intravenous infusions.
They are prescribed to treat severe PsA or PsA that has not responded to other medications. These medicines can suppress the immune system and increase a child's vulnerability to infections.
Physical and occupational therapy can help reduce your child's pain and stiffness, maintain muscle strength, improve mobility, and prevent disability. An occupational therapist might be able to prescribe or recommend splints or braces to protect your child's joints as they grow.
Complementary and alternative medicine is a medical term used to describe medical practices and products that are not part of standard medical care. CAM therapies will not cure or treat your child's PsA, but they can relieve symptoms. CAM options that might be helpful to your child are massage and acupuncture (thin needles applied to specific spots to channel energy).
If your child experiences skin symptoms, topical medicines (applied to the skin) and phototherapy (exposing skin to controlled amounts of ultraviolet light) can help manage and reduce these.
Children who are treated early for PsA can go into remission. Remission means the disease is no longer active and presents few or no symptoms. Your child will still have PsA but they won't experience signs of the condition.
One study reported in 2013 in the journal Pediatric Rheumatology found that 88% of juvenile PsA study participants experienced inactive disease on therapy and 50% off treatment. The study authors noted that these rates were similar to previously reported remission rates.
Even though the potential for remission is higher with early and aggressive treatment, PsA affects children differently. Some may only have involvement in one or two joints and experience a mild disease that is easy to control. Others, however, may have multiple affected joints, have skin and other symptoms, and experience a more severe disease course. But thanks to advances in PsA treatments, most disease complications can be avoided.
Juvenile psoriatic arthritis is a type of juvenile idiopathic arthritis. JIA conditions, like PsA, involve joint inflammation that appears before age 16.
These conditions are autoimmune diseases where the immune system malfunctions and attacks healthy tissues. In the case of PsA, these attacks are focused on the joints and the entheses. Common symptoms of juvenile PsA are joint pain and stiffness, dactylitis, enthesitis, skin rash, and nail symptoms like pitting and crumbling.
Researchers do not know why some children get juvenile PsA and others don't, but they suspect genetics and environmental factors might play a part. While there is no cure for PsA, it is a treatable and manageable condition. Treatment can prevent joint damage and disease complications and lead to disease remission.
Children and teens with juvenile psoriatic arthritis can live normal and happy lives. They can attend school, play sports, and participate in family and extracurricular activities.
Make sure you treat your child with PsA the same way you treat their siblings. It can also be helpful to educate your child about PsA, what causes it, and how to best manage it.
Children should be allowed to express feelings about PsA, including anger. Help your child understand that they didn't do anything to get sick and that it is possible to feel better and enjoy life despite the condition.